Skip to main content
Erschienen in: Diseases of the Colon & Rectum 4/2005

01.04.2005 | Original Contribution

Growth in Epithelial Cell Proliferation and Apoptosis Correlates Specifically to the Inflammation Activity of Inflammatory Bowel Diseases: Ulcerative Colitis Shows Specific p53- and EGFR Expression Alterations

verfasst von: Ferenc Sipos, M.D., Béla Molnár, M.D., Ph.D., Tamás Zágoni, M.D., Lajos Berczi, M.D., Zsolt Tulassay, M.D., D.Sc.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

PURPOSE

Epithelial cell turnover related differences between ulcerative colitis, Crohn’s colitis, and aspecific colitis are not known yet.

METHODS

Totally 345 formalin-fixed, paraffin-embedded biopsy specimens from 33 ulcerative colitis, 26 Crohn’s colitis, 30 aspecific colitis, and 10 healthy patients were observed with the TdT-mediated dUTP nick end labeling method and proliferating cell nuclear antigen-, p53-, and epithelial growth factor receptor immunohistochemistry. Because of epithelial growth factor receptor positivity of subepithelial cells epithelial growth factor receptor and CD45, CD68, or CD83 double fluorescence immunohistochemistry were performed on 16 freshly frozen samples from 8 severely active ulcerative colitis and 8 severely active Crohn’s colitis patients to describe lamina propria’s mononuclear cells, respectively.

RESULTS

The epithelial growth factor receptor expression was significantly lower in each inflammatory group compared with normal (P < 0.005) and decreased significantly in mild ulcerative colitis compared with mild Crohn’s colitis or aspecific colitis (P < 0.005). Numerous epithelial growth factor receptor and CD45 double-positive submucosal mononuclear cells were observed in moderate-severe inflammations. The p53-expression was significantly higher in each inflammatory group compared with normal (P < 0.05). Significant differences were found between mildly, moderately, and severely inflamed samples in ulcerative colitis (P < 0.05) compared with Crohn’s colitis or aspecific colitis. Apoptotic/proliferative rates increased significantly in line with the inflammatory process (P < 0.0001/0.05), but the TdT-mediated dUTP nick end labeling and proliferating cell nuclear antigen-labeling characteristics did not show disease type specificity.

CONCLUSIONS

Based on our results, the alterations of epithelial growth factor receptor and p53 expression show ulcerative colitis specificity, whereas the rate of epithelial apoptosis and proliferation are determined by the histologic activity of the inflammation. The increased epithelial growth factor receptor expression by the lamina propria’s mononuclear cells in inflammation may suggest its role as an autoantigen.
Literatur
1.
Zurück zum Zitat Lindberg, BU, Broome, U, Persson, B 2001Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance studyDis Colon Rectum447785PubMed Lindberg, BU, Broome, U, Persson, B 2001Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance studyDis Colon Rectum447785PubMed
2.
Zurück zum Zitat Sato, A, Machinami, R 1999p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinomaPathol Int4985868CrossRefPubMed Sato, A, Machinami, R 1999p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinomaPathol Int4985868CrossRefPubMed
3.
Zurück zum Zitat Levine, AD 2000Apoptosis: implications for inflammatory bowel diseaseInflamm Bowel Dis6191205PubMedCrossRef Levine, AD 2000Apoptosis: implications for inflammatory bowel diseaseInflamm Bowel Dis6191205PubMedCrossRef
4.
Zurück zum Zitat Dignass, AU 2001Mechanisms and modulation of intestinal epithelial repairInflamm Bowel Dis76877PubMed Dignass, AU 2001Mechanisms and modulation of intestinal epithelial repairInflamm Bowel Dis76877PubMed
5.
Zurück zum Zitat Noffsinger, A, Unger, B, Fenoglio-Preiser, CM 1998Increased cell proliferation characterizes Crohn’s diseaseMod Pathol111198203PubMed Noffsinger, A, Unger, B, Fenoglio-Preiser, CM 1998Increased cell proliferation characterizes Crohn’s diseaseMod Pathol111198203PubMed
6.
Zurück zum Zitat Boirivant, M, Marini, M, Di Felice, G, et al. 1999Lamina propria T cells in Crohn’s disease and other gastrointestinal inflammation show defective CD2-pathway-induced apoptosisGastroenterology11655765PubMed Boirivant, M, Marini, M, Di Felice, G,  et al. 1999Lamina propria T cells in Crohn’s disease and other gastrointestinal inflammation show defective CD2-pathway-induced apoptosisGastroenterology11655765PubMed
7.
Zurück zum Zitat Fiocchi, C 1998Inflammatory bowel disease: etiology and pathogenesisGastroenterology115182205PubMed Fiocchi, C 1998Inflammatory bowel disease: etiology and pathogenesisGastroenterology115182205PubMed
8.
Zurück zum Zitat Serafini, EP, Kirk, AP, Chambers, TJ 1981Rate and pattern of epithelial cell proliferation in ulcerative colitisGut2264852PubMed Serafini, EP, Kirk, AP, Chambers, TJ 1981Rate and pattern of epithelial cell proliferation in ulcerative colitisGut2264852PubMed
10.
Zurück zum Zitat Újszaaszy, L, Jenkins, D 1999Vezérfonal a gyulladásos vastagbélbetegségek hisztopatológiai megítéléséhez.Hungarian Society of Gastroenterology and Medicom Glaxo WelcomeBudapest-Miskolc Újszaaszy, L, Jenkins, D 1999Vezérfonal a gyulladásos vastagbélbetegségek hisztopatológiai megítéléséhez.Hungarian Society of Gastroenterology and Medicom Glaxo WelcomeBudapest-Miskolc
11.
Zurück zum Zitat Kullmann, F, Fadaie, M, Gross, V, et al. 1996Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel diseaseEur J Gastroenterol Hepatol837179PubMed Kullmann, F, Fadaie, M, Gross, V,  et al. 1996Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel diseaseEur J Gastroenterol Hepatol837179PubMed
12.
Zurück zum Zitat Kovac, D, Rubinic, M, Krasevic, M, et al. 1995Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancerAnticancer Res1523012PubMed Kovac, D, Rubinic, M, Krasevic, M,  et al. 1995Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancerAnticancer Res1523012PubMed
13.
Zurück zum Zitat Koornstra, JJ, Rijcken, FE, de Jong, S, Hollema, H, de Vries, EG, Kleibeuker, JH 2004Assessment of apoptosis by M30 immunoreactivity and the correlation with morphological criteria in normal colorectal mucosa, adenomas and carcinomasHistopathology44917CrossRefPubMed Koornstra, JJ, Rijcken, FE, de Jong, S, Hollema, H, de Vries, EG, Kleibeuker, JH 2004Assessment of apoptosis by M30 immunoreactivity and the correlation with morphological criteria in normal colorectal mucosa, adenomas and carcinomasHistopathology44917CrossRefPubMed
14.
Zurück zum Zitat Henning, T, Kraus, M, Brischwein, M, Otto, AM, Wolf, B 2004Relevance of tumor microenvironment for progression, therapy and drug developmentAnticancer Drugs15714CrossRefPubMed Henning, T, Kraus, M, Brischwein, M, Otto, AM, Wolf, B 2004Relevance of tumor microenvironment for progression, therapy and drug developmentAnticancer Drugs15714CrossRefPubMed
15.
Zurück zum Zitat Grossman, D, Kim, PJ, Blanc-Brude, OP, et al. 2001Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53J Clin Invest1089919CrossRefPubMed Grossman, D, Kim, PJ, Blanc-Brude, OP,  et al. 2001Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53J Clin Invest1089919CrossRefPubMed
16.
Zurück zum Zitat McGarrity, TJ, Peiffer, LP, Billingsley, ML 1999Overexpression of epidermal growth factor receptor in Peutz-Jeghers syndromeDig Dis Sci44113641CrossRefPubMed McGarrity, TJ, Peiffer, LP, Billingsley, ML 1999Overexpression of epidermal growth factor receptor in Peutz-Jeghers syndromeDig Dis Sci44113641CrossRefPubMed
17.
Zurück zum Zitat Iwamoto, M, Koji, T, Makiyama, N, Kobayashi, N, Nakane, PK 1996Apoptosis of crypt epithelial cells in ulcerative colitisJ Pathol1801529CrossRefPubMed Iwamoto, M, Koji, T, Makiyama, N, Kobayashi, N, Nakane, PK 1996Apoptosis of crypt epithelial cells in ulcerative colitisJ Pathol1801529CrossRefPubMed
18.
Zurück zum Zitat Strädater, J, Wellisch, I, Riedl, S, et al. 1997CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitisGastroenterology1131607PubMed Strädater, J, Wellisch, I, Riedl, S,  et al. 1997CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitisGastroenterology1131607PubMed
19.
Zurück zum Zitat Ueyama, H, Kiyohara, T, Sawada, N, et al. 1998High Fas ligand expression on lymphocytes in lesions of ulcerative colitisGut434855PubMedCrossRef Ueyama, H, Kiyohara, T, Sawada, N,  et al. 1998High Fas ligand expression on lymphocytes in lesions of ulcerative colitisGut434855PubMedCrossRef
20.
Zurück zum Zitat Itoh, J, De la Motte, C, Stong, SA, Levine, AD, Fiocchi, C 2001Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn’s diseaseGut493541CrossRefPubMed Itoh, J, De la Motte, C, Stong, SA, Levine, AD, Fiocchi, C 2001Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn’s diseaseGut493541CrossRefPubMed
21.
Zurück zum Zitat Roman, LI, Manzano, L, De la Hera, A, Abreu, L, Rossi, I, Alvarez-Mon, M 1996Expanded CD4+ CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn’s diseaseGastroenterology110100819PubMed Roman, LI, Manzano, L, De la Hera, A, Abreu, L, Rossi, I, Alvarez-Mon, M 1996Expanded CD4+ CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn’s diseaseGastroenterology110100819PubMed
22.
Zurück zum Zitat Rüthlein, J, Heinze, G, Auer, IO 1992Anti-CD2 and anti-CD3 induced T cell cytotoxicity of human intraepithelial and lamina propria lymphocytesGut33162632PubMed Rüthlein, J, Heinze, G, Auer, IO 1992Anti-CD2 and anti-CD3 induced T cell cytotoxicity of human intraepithelial and lamina propria lymphocytesGut33162632PubMed
23.
Zurück zum Zitat De Maria, R, Boirivant, M, Cifone, MG, et al. 1996Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytesJ Clin Invest9719PubMed De Maria, R, Boirivant, M, Cifone, MG,  et al. 1996Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytesJ Clin Invest9719PubMed
24.
Zurück zum Zitat Arai, N, Mitomi, H, Ohtani, Y, Igarashi, M, Kakita, A, Okayasu, I 1999Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitisMod Pathol1260411PubMed Arai, N, Mitomi, H, Ohtani, Y, Igarashi, M, Kakita, A, Okayasu, I 1999Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitisMod Pathol1260411PubMed
25.
Zurück zum Zitat Arato, A, Savilahti, E, Paszti, I 1994Crypt hyperplasia related to increased lymphocyte activation in the rectal mucosa of children with ulcerative colitisZ Gastroenterol324837PubMed Arato, A, Savilahti, E, Paszti, I 1994Crypt hyperplasia related to increased lymphocyte activation in the rectal mucosa of children with ulcerative colitisZ Gastroenterol324837PubMed
26.
27.
Zurück zum Zitat Kastan, MB, Onyekwere, O, Sidransky, D, Vogelstein, B, Craig, RW 1991Participation of p53 protein in the cellular response to DNA damageCancer Res51630411PubMed Kastan, MB, Onyekwere, O, Sidransky, D, Vogelstein, B, Craig, RW 1991Participation of p53 protein in the cellular response to DNA damageCancer Res51630411PubMed
28.
Zurück zum Zitat Van den Berg, FM, Tigges, AJ, Schipper, ME, den Hartog-Jager, FC, Kroes, WG, Walboomers, JM 1989Expression of the nuclear oncogene p53 in colon tumoursJ Pathol1571939PubMed Van den Berg, FM, Tigges, AJ, Schipper, ME, den Hartog-Jager, FC, Kroes, WG, Walboomers, JM 1989Expression of the nuclear oncogene p53 in colon tumoursJ Pathol1571939PubMed
29.
Zurück zum Zitat Chaubert, P, Benhattar, J, Saraga, E, Costa, J 1994K-ras mutations and p53 alterations in neoplastic lesions and nonneoplastic lesions associated with longstanding ulcerative colitisAm J Pathol14476775PubMed Chaubert, P, Benhattar, J, Saraga, E, Costa, J 1994K-ras mutations and p53 alterations in neoplastic lesions and nonneoplastic lesions associated with longstanding ulcerative colitisAm J Pathol14476775PubMed
30.
Zurück zum Zitat Kawasaki, Y, Monden, T, Morimoto, H, et al. 1992Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenomaAm J Clin Pathol9724449PubMed Kawasaki, Y, Monden, T, Morimoto, H,  et al. 1992Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenomaAm J Clin Pathol9724449PubMed
31.
Zurück zum Zitat Noffsinger, AE, Belli, JM, Miller, MA, Fenoglio-Preiser, CM 2001A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 geneHistopathology3948292PubMed Noffsinger, AE, Belli, JM, Miller, MA, Fenoglio-Preiser, CM 2001A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 geneHistopathology3948292PubMed
32.
Zurück zum Zitat Uesugi, H, Mitomi, H, Sada, M, et al. 1999A case of adenocarcinoma of the small intestine in a Japanese patient with Crohn’s disease: a report with immunohistochemical and oncogenic analysesScand J Gastroenterol34116267PubMed Uesugi, H, Mitomi, H, Sada, M,  et al. 1999A case of adenocarcinoma of the small intestine in a Japanese patient with Crohn’s disease: a report with immunohistochemical and oncogenic analysesScand J Gastroenterol34116267PubMed
33.
Zurück zum Zitat Friess, H, Wang, L, Zhu, Z, et al. 1999Growth factor receptors are differentially expressed in cancers of the papilla Vater and pancreasAnn Surg23076774PubMed Friess, H, Wang, L, Zhu, Z,  et al. 1999Growth factor receptors are differentially expressed in cancers of the papilla Vater and pancreasAnn Surg23076774PubMed
34.
Zurück zum Zitat Dignass, AU, Sturm, A 2001Peptide growth factors in the intestineEur J Gastroenterol Hepatol1376370PubMed Dignass, AU, Sturm, A 2001Peptide growth factors in the intestineEur J Gastroenterol Hepatol1376370PubMed
35.
Zurück zum Zitat Messa, C, Russo, F, Caruso, MG, Di Leo, A 1998EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinomaActa Oncol372859PubMed Messa, C, Russo, F, Caruso, MG, Di Leo, A 1998EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinomaActa Oncol372859PubMed
36.
Zurück zum Zitat Ozgul, C, Karaoz, E, Erdogan, D, Dursun, A 1997Expression of epidermal growth factor receptor in normal colonic mucosa and in adenocarcinoma of the colonActa Physiol Hung851218PubMed Ozgul, C, Karaoz, E, Erdogan, D, Dursun, A 1997Expression of epidermal growth factor receptor in normal colonic mucosa and in adenocarcinoma of the colonActa Physiol Hung851218PubMed
37.
Zurück zum Zitat Hormi, K, Cadiot, G, Kermorgant, S, et al. 2000Transforming growth factor-alpha and epidermal growth factor receptor in colonic mucosa in active and inactive inflammatory bowel diseaseGrowth Factors187991PubMedCrossRef Hormi, K, Cadiot, G, Kermorgant, S,  et al. 2000Transforming growth factor-alpha and epidermal growth factor receptor in colonic mucosa in active and inactive inflammatory bowel diseaseGrowth Factors187991PubMedCrossRef
Metadaten
Titel
Growth in Epithelial Cell Proliferation and Apoptosis Correlates Specifically to the Inflammation Activity of Inflammatory Bowel Diseases: Ulcerative Colitis Shows Specific p53- and EGFR Expression Alterations
verfasst von
Ferenc Sipos, M.D.
Béla Molnár, M.D., Ph.D.
Tamás Zágoni, M.D.
Lajos Berczi, M.D.
Zsolt Tulassay, M.D., D.Sc.
Publikationsdatum
01.04.2005
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 4/2005
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-004-0831-5

Weitere Artikel der Ausgabe 4/2005

Diseases of the Colon & Rectum 4/2005 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.